218 related articles for article (PubMed ID: 29272035)
1. Composite ganglioside autoantibodies and immune treatment response in MMN and MADSAM.
Martinez-Thompson JM; Snyder MR; Ettore M; McKeon A; Pittock SJ; Roforth MM; Mandrekar J; Mauermann ML; Taylor BV; Dyck PJB; Windebank AJ; Klein CJ
Muscle Nerve; 2018 Jun; 57(6):1000-1005. PubMed ID: 29272035
[TBL] [Abstract][Full Text] [Related]
2. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies.
Nobile-Orazio E; Giannotta C; Briani C
J Neuroimmunol; 2010 Feb; 219(1-2):119-22. PubMed ID: 20006388
[TBL] [Abstract][Full Text] [Related]
3. Analysis of anti-ganglioside antibodies by a line immunoassay in patients with chronic-inflammatory demyelinating polyneuropathies (CIDP).
Klehmet J; Märschenz S; Ruprecht K; Wunderlich B; Büttner T; Hiemann R; Roggenbuck D; Meisel A
Clin Chem Lab Med; 2018 May; 56(6):919-926. PubMed ID: 29329103
[TBL] [Abstract][Full Text] [Related]
4. Childhood-onset multifocal motor neuropathy with IgM antibodies to GM2 and GalNac-GD1a.
Maeda H; Ishii R; Kusunoki S; Chiyonobu T
Brain Dev; 2020 Jan; 42(1):88-92. PubMed ID: 31522790
[TBL] [Abstract][Full Text] [Related]
5. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
[TBL] [Abstract][Full Text] [Related]
6. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
7. Increased IP-10 production by blood-nerve barrier in multifocal acquired demyelinating sensory and motor neuropathy and multifocal motor neuropathy.
Shimizu F; Oishi M; Sawai S; Beppu M; Misawa S; Matsui N; Miyashiro A; Maeda T; Takeshita Y; Nishihara H; Sano Y; Sato R; Kaji R; Kuwabara S; Kanda T
J Neurol Neurosurg Psychiatry; 2019 Apr; 90(4):444-450. PubMed ID: 30523038
[TBL] [Abstract][Full Text] [Related]
8. Pure Motor Onset and IgM-Gammopathy Occurrence in Multifocal Acquired Demyelinating Sensory and Motor Neuropathy.
Beecher G; Shelly S; Dyck PJB; Mauermann ML; Martinez-Thompson JM; Berini SE; Naddaf E; Shouman K; Taylor BV; Dyck PJ; Engelstad J; Howe BM; Mills JR; Dubey D; Spinner RJ; Klein CJ
Neurology; 2021 Oct; 97(14):e1392-e1403. PubMed ID: 34376509
[TBL] [Abstract][Full Text] [Related]
9. Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome.
Saperstein DS; Amato AA; Wolfe GI; Katz JS; Nations SP; Jackson CE; Bryan WW; Burns DK; Barohn RJ
Muscle Nerve; 1999 May; 22(5):560-6. PubMed ID: 10331353
[TBL] [Abstract][Full Text] [Related]
10. Systematic reviews of treatment for chronic inflammatory demyelinating neuropathy.
Hughes RA
Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S32-6. PubMed ID: 12690659
[TBL] [Abstract][Full Text] [Related]
11. Plexus MRI helps distinguish the immune-mediated neuropathies MADSAM and MMN.
Beecher G; Howe BM; Shelly S; Staff NP; Mauermann ML; Taylor BV; Spinner RJ; Tracy JA; Dyck PJB; Klein CJ
J Neuroimmunol; 2022 Oct; 371():577953. PubMed ID: 36007424
[TBL] [Abstract][Full Text] [Related]
12. Therapy of CIDP and related immune-mediated neuropathies.
Koski CL
Neurology; 2002 Dec; 59(12 Suppl 6):S22-7. PubMed ID: 12499467
[TBL] [Abstract][Full Text] [Related]
13. [Intravenous immunoglobulin-induced eczematous eruption in autoimmune neuromuscular diseases].
Hatake S; Shimizu F; Honda M; Takahashi S; Koga M; Kimura K; Kanda T
Rinsho Shinkeigaku; 2022 Apr; 62(4):267-271. PubMed ID: 35354723
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric Acquired Demyelinating Polyneuropathies: MMN and MADSAM.
Katz JS; Saperstein DS
Curr Treat Options Neurol; 2001 Mar; 3(2):119-125. PubMed ID: 11180748
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound pattern sum score, homogeneity score and regional nerve enlargement index for differentiation of demyelinating inflammatory and hereditary neuropathies.
Grimm A; Vittore D; Schubert V; Lipski C; Heiling B; Décard BF; Axer H
Clin Neurophysiol; 2016 Jul; 127(7):2618-24. PubMed ID: 27291881
[TBL] [Abstract][Full Text] [Related]
16. Sensory loss in multifocal motor neuropathy: a clinical and electrophysiological study.
Lambrecq V; Krim E; Rouanet-Larrivière M; Lagueny A
Muscle Nerve; 2009 Feb; 39(2):131-6. PubMed ID: 19127532
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and long-term characteristics of the subtypes of chronic inflammatory demyelinating polyneuropathy].
Shimizu F; Nemoto J; Takeshita Y; Maeda T; Koga M; Kanda T
Rinsho Shinkeigaku; 2022 Mar; 62(3):173-177. PubMed ID: 35228460
[TBL] [Abstract][Full Text] [Related]
18. Bochum ultrasound score allows distinction of chronic inflammatory from multifocal acquired demyelinating polyneuropathies.
Kerasnoudis A; Pitarokoili K; Gold R; Yoon MS
J Neurol Sci; 2015 Jan; 348(1-2):211-5. PubMed ID: 25534358
[TBL] [Abstract][Full Text] [Related]
19. Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
Boërio D; Créange A; Hogrel JY; Guéguen A; Bertrand D; Lefaucheur JP
J Neurol Sci; 2010 May; 292(1-2):63-71. PubMed ID: 20219211
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Kuwahara M; Suzuki S; Takada K; Kusunoki S
J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
